Alkermes PLC (ALKS)
28.00
-0.16
(-0.55%)
USD |
NASDAQ |
Sep 29, 16:00
28.00
0.00 (0.00%)
After-Hours: 20:00
Alkermes Enterprise Value: 4.153B for Sept. 28, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 28, 2023 | 4.153B |
| September 27, 2023 | 4.220B |
| September 26, 2023 | 4.288B |
| September 25, 2023 | 4.310B |
| September 22, 2023 | 4.296B |
| September 21, 2023 | 4.411B |
| September 20, 2023 | 4.486B |
| September 19, 2023 | 4.445B |
| September 18, 2023 | 4.448B |
| September 15, 2023 | 4.393B |
| September 14, 2023 | 4.435B |
| September 13, 2023 | 4.428B |
| September 12, 2023 | 4.565B |
| September 11, 2023 | 4.380B |
| September 08, 2023 | 4.268B |
| September 07, 2023 | 4.325B |
| September 06, 2023 | 4.380B |
| September 05, 2023 | 4.325B |
| September 01, 2023 | 4.338B |
| August 31, 2023 | 4.325B |
| August 30, 2023 | 4.311B |
| August 29, 2023 | 3.990B |
| August 28, 2023 | 3.997B |
| August 25, 2023 | 3.988B |
| August 24, 2023 | 4.053B |
| Date | Value |
|---|---|
| August 23, 2023 | 4.112B |
| August 22, 2023 | 4.375B |
| August 21, 2023 | 4.400B |
| August 18, 2023 | 4.340B |
| August 17, 2023 | 4.247B |
| August 16, 2023 | 4.291B |
| August 15, 2023 | 4.270B |
| August 14, 2023 | 4.183B |
| August 11, 2023 | 4.132B |
| August 10, 2023 | 4.085B |
| August 09, 2023 | 4.135B |
| August 08, 2023 | 4.157B |
| August 07, 2023 | 4.138B |
| August 04, 2023 | 4.060B |
| August 03, 2023 | 4.065B |
| August 02, 2023 | 4.118B |
| August 01, 2023 | 4.217B |
| July 31, 2023 | 4.340B |
| July 28, 2023 | 4.253B |
| July 27, 2023 | 4.506B |
| July 26, 2023 | 4.468B |
| July 25, 2023 | 4.600B |
| July 24, 2023 | 4.758B |
| July 21, 2023 | 4.780B |
| July 20, 2023 | 4.786B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.812B
Minimum
Mar 18 2020
6.744B
Maximum
Oct 05 2018
3.709B
Average
3.648B
Median
Jan 07 2022
Enterprise Value Benchmarks
| Jazz Pharmaceuticals PLC | 12.63B |
| Medtronic PLC | 121.94B |
| Perrigo Co PLC | 7.838B |
| Horizon Therapeutics PLC | 26.55B |
| Iterum Therapeutics PLC | -3.750M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 237.06M |
| Revenue (Quarterly) | 617.40M |
| Total Expenses (Quarterly) | 378.20M |
| EPS Diluted (Quarterly) | 1.38 |
| Gross Profit Margin (Quarterly) | 73.43% |
| Profit Margin (Quarterly) | 38.40% |
| Earnings Yield | 2.04% |
| Operating Earnings Yield | 2.37% |
| Normalized Earnings Yield | 2.109 |